---
title: Harmonised Standards — Biocompatibility
description: "EU MDR 2017/745 harmonised standards: Biocompatibility (9 standards in the OJ list), applicable to GSPR 10.4. Based on CID (EU) 2021/1182 and amendment 2026/193."
regulation: EU MDR 2017/745
category: Biocompatibility
---

# Harmonised Standards — Biocompatibility

**Official Source**: [EC Health — Harmonised Standards](https://health.ec.europa.eu/medical-devices-topics-interest/harmonised-standards_en) | Based on CID (EU) 2021/1182 (consolidated) and amendment [CID (EU) 2026/193](https://eur-lex.europa.eu/eli/dec_impl/2026/193/oj)

## Harmonised Standards List (9 standards)

| Standard | Title Summary | GSPR Reference | Status |
|----------|--------------|---------------|--------|
| **EN ISO 10993-23:2021** | Part 23: Tests for irritation (ISO 10993-23:2021) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-9:2021** | Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-12:2021** | Part 12: Sample preparation and reference materials (ISO 10993-12:2021) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-10:2023** | Part 10: Tests for skin sensitisation (ISO 10993-10:2021) | GSPR 10.4 (Biocompatibility) | Current |
| **EN 455-3:2023** | Part 3: Requirements and testing for biological evaluation | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-15:2023** | Part 15: Identification and quantification of degradation products from metals and alloys (ISO 10993-15:2019) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-17:2023** | Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-18:2020 + 2023** | Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | GSPR 10.4 (Biocompatibility) | Current |
| **EN ISO 10993-4:2017 + 2025** | Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | GSPR 10.4 (Biocompatibility) | Current |

> **Important**: The following widely-used standards are **not** on the EU MDR harmonised standards list and do not create a presumption of conformity: EN ISO 10993-1 (evaluation framework), EN ISO 10993-3 (genotoxicity), EN ISO 10993-5 (cytotoxicity), EN ISO 10993-6 (implantation), EN ISO 10993-7 (EO residuals), EN ISO 10993-11 (systemic toxicity), EN ISO 10993-13 (polymers). They remain industry-accepted evaluation methods but must be justified separately in the technical file.

## Biocompatibility Evaluation Framework

Material characterisation → Hazard identification → Exposure assessment → Toxicological risk assessment → Biocompatibility conclusion

Under EU MDR, **chemical characterisation takes priority**: toxicological risk assessment (TRA) is performed first; animal testing is only conducted when TRA is insufficient to reach a conclusion.

## Related Pages

- [Annex I — GSPR](../regulations/annex-i-gspr)
- [Harmonised Standards — Sterilization and Packaging](./sterilization)

## Data Layer Source File

[eu_mdr/standards/standards-biocompatibility.json](https://github.com/RASAAS/docmcp-knowledge/tree/main/eu_mdr/standards/standards-biocompatibility.json)
